[Bradykinin receptors: towards new pathophysiological roles]

Area of Science:

• Biochemistry and Pharmacology
• Cardiovascular and Renal Physiology

Context:

• Bradykinin is recognized beyond its pro-inflammatory role, acting as a neuromediator and regulator of vascular and renal functions.
• G-protein coupled receptor signaling pathways are being elucidated for bradykinin's anti-proliferative and anti-fibrogenic effects.
• Transgenic and knockout animal models confirm the protective roles of the bradykinin system in cardiac and renal health.

Purpose:

• To explore the multifaceted roles of bradykinin and its receptors in physiological and pathological processes.
• To investigate the therapeutic implications of bradykinin receptor modulation in cardiovascular and renal diseases.
• To highlight the distinct mechanisms of bradykinin receptor regulation in the central nervous system versus peripheral tissues.

Summary:

• Bradykinin exhibits anti-proliferative and anti-fibrogenic effects through atypical G-protein coupled receptor signaling.
• The bradykinin system is integral to the therapeutic benefits of angiotensin-1 converting enzyme inhibitors for hypertension, heart failure, and diabetes.
• Differential regulation of bradykinin receptors in the CNS and periphery necessitates targeted therapeutic strategies.

Impact:

• Understanding bradykinin's complex roles can lead to novel therapeutic strategies for cardiovascular and renal conditions.
• Development of specific bradykinin receptor agonists or antagonists could offer improved treatment options with reduced side effects.
• This research underscores the therapeutic potential of targeting the bradykinin system in managing chronic diseases.